GlassScriptPhysician profile
Gregory Michael Ziolo
NPI 1972503001
$5,935.51
in general payments reported to CMS, 2019-2025
35 companies · $769 in 2025
The $769 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $412 · 2021: $821 · 2022: $1,097 · 2023: $901 · 2024: $1,256 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,926.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $701.59 | 2019-2025 | |
| Amgen INC. | $696.10 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $569.92 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $441.01 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $436.58 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.02 | 2019-2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $342.16 | 2019-2023 | Livalo |
| Amarin Pharma, INC. | $325.84 | 2019-2022 | |
| Pfizer INC. | $247.60 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $216.22 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $189.12 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $160.06 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $134.02 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $129.11 | 2019-2021 | |
| Irhythm Technologies, INC. | $120.83 | 2021-2024 | Zio Xt Patch, Zio Monitor |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $102.56 | 2023-2024 | Inpefa |
| Heartflow, INC. | $67.77 | 2024-2025 | |
| Medicure Pharma INC. | $66.35 | 2021-2025 | Zypitamag |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.68 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $61.88 | 2021-2025 | Nexletol |
| Philips North America LLC | $56.73 | 2024-2025 | (5044) Mcot, Extended Holter |
| Kiniksa Pharmaceuticals International, Plc | $47.21 | 2024 | Arcalyst |
| Boston Scientific Corporation | $40.85 | 2021-2023 | Watchman |
| Regeneron Healthcare Solutions, INC. | $40.03 | 2019-2022 | |
| Scpharmaceuticals INC. | $39.12 | 2024-2025 | |
| Atricure, INC. | $33.46 | 2023 | |
| Althera Pharmaceuticals LLC | $31.80 | 2021-2022 | |
| Genentech USA, INC. | $25.98 | 2019 | |
| Lilly USA, LLC | $21.22 | 2025 | Zepbound |
| Alnylam Pharmaceuticals INC. | $18.43 | 2024 | Onpattro |
| 180 Medical, INC. | $17.19 | 2022 | |
| Kestra Medical Technology Services, INC. | $15.54 | 2024 | Assure Wcd |
| Cashflow Solutions, LLC | $13.76 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Abbott Laboratories | $13.76 | 2022 | |
| Baxter Healthcare | $13.01 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ziolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.